
Limospas 75mg Injection
Marketer
Ancalima Lifesciences Ltd
Salt Composition
Diclofenac (75mg)
Overview Limospas 75mg Injection
Rheumaject 75mg injection provides analgesia. Indicated for pain management, inflammation, rigidity, and arthralgia associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral intake is infeasible. Injection must be given by a qualified medical practitioner; self-administration is strictly prohibited. Pre-existing cardiovascular disease or cerebrovascular accident should be disclosed to your physician. Report any injection site reactions (pain, edema, erythema) immediately. Common adverse events include nausea, emesis, cephalgia, and local injection site effects. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood parameters. Chronic use carries a risk of gastrointestinal hemorrhage and nephropathy.
Primary Ingredients of Limospas 75mg Injection
No text provided to rephrase.
Uses of Limospas 75mg Injection
Analgesia
Major Benefits of Limospas 75mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Limospas 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Limospas 75mg Injection:
Administering this medication will be handled by your physician or their registered nurse; self-medication is strictly prohibited.
How Limospas 75mg Injection works:
Limospas 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and edema.
SAFETY ADVICE
AlcoholCAUTION
Limospas 75mg Injection should be used cautiously with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Limospas 75mg Injection during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The administration of Limospas 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Limospas 75mg Injection might result in adverse reactions that could impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Limospas 75mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of 75mg Limospas Injection requires careful monitoring. Dosage modification of Limospas 75mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Limospas 75mg Injection :
Omit a Limospas 75mg Injection dose? Seek medical advice.
Facts to Know About Limospas 75mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic acid analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
